Gabapentin
Brand names: Neurontin
Gabapentin is an antiepileptic and neuropathic-pain agent used for neuropathic pain and as adjunctive seizure therapy; in older people sedation, falls and renal dosing are central concerns.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It binds the alpha-2-delta subunit of voltage-gated calcium channels, reducing excitatory neurotransmitter release and modulating neuronal excitability.
Prescribing in practice
- It is renally cleared, so reduce the dose in renal impairment common in older people, and titrate slowly to limit dizziness, sedation and falls.
- Gabapentin is a controlled drug with potential for misuse and dependence; the combination with opioids increases the risk of respiratory depression and sedation.
- Withdraw gradually to avoid withdrawal symptoms and, in epilepsy, the risk of rebound seizures.
Monitoring
Monitor for sedation, dizziness, mood changes and falls, and review renal function as a guide to dosing.
Counselling the patient
- Drowsiness and dizziness are common at first; take care with driving and avoid falls.
- Do not stop suddenly, as this can cause withdrawal effects.
- Tell your team about opioid painkillers, as the combination can dangerously slow breathing.
Evidence & guidelines
MHRA guidance reclassified gabapentin as a controlled drug and warns of respiratory depression with concomitant opioids or in those with reduced respiratory reserve, including older patients.
Reference: NICE CG173 (Neuropathic Pain); MHRA Drug Safety Update 2017; AGS Beers Criteria 2023; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Falls Assessment in Older Adults · NICE CG161 2013
- Delirium Outside ICU · NICE CG103
- Comprehensive Geriatric Assessment (CGA) · BGS / NICE
- Delirium Assessment and Management · NICE CG103 2010
- Frailty Recognition and Management · BGS Frailty Framework / NHS NHSE
- Polypharmacy and Medicines Optimisation · STOPP/START v2 2014 / NICE NG5